CLINICAL GUIDELINES
| Issue | Title | File | |
| Vol 48, No 6 (2020) | Early administration of genetically engineered biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An experts’ opinion |
 (Rus) |
|
| Abdulganieva D.I., Bakulev A.L., Belousova E.A., Veselov A.V., Korotaeva T.V., Lila A.M., Loginova E.Y., Sokolovskiy E.V., Khobeysh M.M., Shapina M.V., Shchukina O.B. | |||
| 1 - 1 of 1 Items | |||